Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.059x

Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million ≈ $13.28 Million USD) by net assets (CN¥1.53 Billion ≈ $223.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Luoxin Pharmaceuticals Group Stock Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Luoxin Pharmaceuticals Group Stock Co Lt for a breakdown of total debt and financial obligations.

Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
PARATUS ENERGY SERVICES LTD OL:PLSV	0.038x
Baotailong New Materials Co Ltd SHG:601011	-0.012x
Stevanato Group SpA NYSE:STVN	0.062x
United Overseas Australia Ltd AU:UOS	0.030x
BlackRock Health Sciences Trust II NYSE:BMEZ	0.103x
Orezone Gold Corporation AU:ORE	0.007x
Nanjing Quanxin Cable Technology Co Ltd SHE:300447	0.031x
Citic Guoan Wine Co Ltd SHG:600084	0.005x

Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Luoxin Pharmaceuticals Group Stock Co Lt.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.46 Billion ≈ $213.56 Million	CN¥-157.85 Million ≈ $-23.10 Million	-0.108x	-150.33%
2023-12-31	CN¥2.57 Billion ≈ $376.42 Million	CN¥552.79 Million ≈ $80.89 Million	0.215x	+175.66%
2022-12-31	CN¥3.31 Billion ≈ $483.84 Million	CN¥-939.13 Million ≈ $-137.42 Million	-0.284x	-1215.03%
2021-12-31	CN¥4.74 Billion ≈ $692.99 Million	CN¥120.63 Million ≈ $17.65 Million	0.025x	+442.04%
2020-12-31	CN¥4.35 Billion ≈ $636.59 Million	CN¥-32.40 Million ≈ $-4.74 Million	-0.007x	-125.36%
2019-12-31	CN¥3.96 Billion ≈ $579.73 Million	CN¥116.33 Million ≈ $17.02 Million	0.029x	-76.59%
2018-12-31	CN¥909.89 Million ≈ $133.14 Million	CN¥114.12 Million ≈ $16.70 Million	0.125x	-7.52%
2017-12-31	CN¥754.19 Million ≈ $110.36 Million	CN¥102.27 Million ≈ $14.97 Million	0.136x	+30.19%
2016-12-31	CN¥698.33 Million ≈ $102.19 Million	CN¥72.74 Million ≈ $10.64 Million	0.104x	-39.16%
2015-12-31	CN¥339.50 Million ≈ $49.68 Million	CN¥58.12 Million ≈ $8.51 Million	0.171x	+29.11%
2014-12-31	CN¥315.46 Million ≈ $46.16 Million	CN¥41.83 Million ≈ $6.12 Million	0.133x	-48.50%
2013-12-31	CN¥251.50 Million ≈ $36.80 Million	CN¥64.75 Million ≈ $9.48 Million	0.257x	+58.84%
2012-12-31	CN¥205.54 Million ≈ $30.08 Million	CN¥33.31 Million ≈ $4.88 Million	0.162x	-47.10%
2011-12-31	CN¥151.87 Million ≈ $22.22 Million	CN¥46.53 Million ≈ $6.81 Million	0.306x	--

About Luoxin Pharmaceuticals Group Stock Co Ltd

SHE:002793 China Drug Manufacturers - Specialty & Generic

Market Cap

$880.09 Million

CN¥6.01 Billion CNY

Market Cap Rank

#9688 Global

#2713 in China

Share Price

CN¥5.53

Change (1 day)

+2.60%

52-Week Range

CN¥4.25 - CN¥6.50

All Time High

CN¥25.07